Marker Therapeutics Inc (MRKR)

[Bio7mm]

Hopefully the large institutions like Tonaquint that own our debt (hopefully converted to preferred shares) will also participate in a capital raise after the RS. Speculation on my part but it is what we need to restart the engine. Our management is converting their preferred shares to common at the time of the RS. Probably to free up the 5 million preferred shares authorized in our capital structure for the holders (Tonaquint and others) of our debt. We need a clean balance sheet for the capital raise to occur. Management probably has a plan for maintaining momentum and interest in TPIV after the RS. They want the stock to go up too since they will own a lot of it on Feb. 17! Speculation on my part but I have seen this scenario play out at other biotechs. Don't mistake their lack of news since early Oct for a lack of activity. Many things have probably been going on behind the scenes.